Two Sigma Investments
HLVX

Two Sigma Investments’s HilleVax HLVX Stock Holding History

Two Sigma Investments’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-170,209
Closed -$339K – 3767
2025
Q2 		$339K Buy
170,209
+79,494
+88% +$145K ﹤0.01% 2747
2025
Q1 		$132K Buy
90,715
+35,180
+63% +$65K ﹤0.01% 2923
2024
Q4 		$115K Buy
55,535
+24,039
+76% +$45.1K ﹤0.01% 2949
2024
Q3 		$55.4K Sell
31,496
-44,912
-59% -$115K ﹤0.01% 2962
2024
Q2 		$1.1M Buy
76,408
+38,786
+103% +$533K ﹤0.01% 1931
2024
Q1 		$626K Buy
37,622
+7,555
+25% +$121K ﹤0.01% 2227
2023
Q4 		$483K Buy
+30,067
New +$399K ﹤0.01% 2480
2022
Q4 		– Sell
-20,500
Closed -$350K – 2915
2022
Q3 		$350K Sell
20,500
-109,500
-84% -$1.59M ﹤0.01% 1913
2022
Q2 		$1.42M Buy
+130,000
New +$1.54M ﹤0.01% 1374

Two Sigma Investments's HLVX Position: Q3 2025 in Review

Two Sigma Investments sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 170,209 shares — an estimated $339K sold.

Two Sigma Investments first reported a position in HLVX in Q2 2022 and held it in 9 quarters. The position peaked at $1.42M in Q2 2022. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Two Sigma Investments reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 170,209 HilleVax shares in Q3 2025, an estimated $339K.
  • Two Sigma Investments first reported a position in HilleVax in Q2 2022 and held it in 9 quarters.
  • Two Sigma Investments's HilleVax position peaked at $1.42M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.